Nephrology · South Charleston, WV
NPI
1730174970
Since 2005
Specialty
Nephrology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
24 Maccorkle Ave SW, Suite 201
South Charleston, WV, 25303
Phone (304) 720-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.9M
230,588 services
Medicare patients, 2024
384
Average age 73
Drug cost, 2024
$4.2M
7,093 prescriptions
Company payments, 2025
$31K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Julian L Espiritu was code J1071 (injection, testosterone cypionate, 1 mg), 151,200 times for 53 patients. In total Julian L Espiritu billed 230,588 services in 89 codes, and Medicare paid $1.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 151,200 | 53 | $0.02 | $2,722 |
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 27,000 | 21 | $0.86 | $23K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 20,790 | 17 | $8.58 | $178K |
| J1756 Injection, iron sucrose, 1 mg | Office | 8,900 | 11 | $0.15 | $1,294 |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 5,630 | 11 | $2.28 | $13K |
| J0897 Injection, denosumab, 1 mg | Office | 3,000 | 34 | $20.41 | $61K |
| 96372 Injection Administration | Office | 1,402 | 151 | $10.35 | $15K |
| 36415 Venipuncture Blood Collection | Office | 961 | 299 | $8.62 | $8,285 |
| 85027 Blood Count | Office | 816 | 294 | $6.32 | $5,154 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 688 | 100 | $0.88 | $605 |
| 81003 Clinical Chemistry | Office | 656 | 294 | $2.19 | $1,434 |
| 82570 Clinical Chemistry | Office | 632 | 291 | $5.06 | $3,199 |
| 82043 Clinical Chemistry | Office | 623 | 283 | $5.64 | $3,513 |
| 84550 Clinical Chemistry | Office | 606 | 270 | $4.41 | $2,674 |
| 80053 Clinical Chemistry | Office | 585 | 280 | $10.31 | $6,031 |
By year: 2022 $2.5M for 364,870 services; 2023 $1.4M for 310,103 services; 2024 $1.9M for 230,588 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 961 | 299 | $8.62 | $8,285 |
| 85027 Blood Count | 816 | 294 | $6.32 | $5,154 |
| 81003 Clinical Chemistry | 656 | 294 | $2.19 | $1,434 |
| 82570 Clinical Chemistry | 632 | 291 | $5.06 | $3,199 |
| 82043 Clinical Chemistry | 623 | 283 | $5.64 | $3,513 |
| 84550 Clinical Chemistry | 606 | 270 | $4.41 | $2,674 |
| 80053 Clinical Chemistry | 585 | 280 | $10.31 | $6,031 |
| 83735 Clinical Chemistry | 524 | 262 | $6.54 | $3,427 |
| 83970 Clinical Chemistry | 441 | 258 | $40.19 | $18K |
| 84466 Clinical Chemistry | 316 | 179 | $12.47 | $3,940 |
Medicare prescription drug claims, 2024
In 2024, the drug Julian L Espiritu prescribed most often to Medicare patients was Losartan Potassium, with 571 prescriptions and refills. In total Julian L Espiritu wrote 7,093 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Losartan Potassium Generic | 571 | 1,549 | 166 | $5,114 |
| Jardiance Empagliflozin | 502 | 1,137 | 175 | $643K |
| Allopurinol Generic | 379 | 1,005 | 113 | $3,745 |
| Farxiga Dapagliflozin Propanediol | 376 | 856 | 104 | $474K |
| Ozempic Semaglutide | 328 | 544 | 101 | $513K |
| Vascepa Icosapent Ethyl | 325 | 752 | 92 | $256K |
| Mounjaro Tirzepatide | 288 | 422 | 59 | $438K |
| Amlodipine Besylate Generic | 192 | 497 | 68 | $768 |
| Metformin Hcl Generic | 186 | 472 | 56 | $934 |
| Carvedilol Generic | 158 | 410 | 43 | $1,359 |
| Trulicity Dulaglutide | 123 | 176 | 32 | $173K |
| Furosemide Generic | 120 | 287 | 45 | $758 |
| Kerendia Finerenone | 113 | 265 | 30 | $167K |
| Calcitriol Generic | 101 | 265 | 30 | $2,120 |
| Levothyroxine Sodium Generic | 98 | 278 | 27 | $1,143 |
Brand drugs: 2,503 claims; generic drugs: 4,575 claims; opioid claims: 58.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Julian L Espiritu $31K ($31K in general payments such as food, travel and fees) from 19 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $18K.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 25 | $18K |
| Amgen Inc. AMGN | 75 | $7,395 |
| Lilly USA, LLC LLY | 6 | $3,392 |
| Novo Nordisk Inc NVO | 9 | $378 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $365 |
| ANI Pharmaceuticals, Inc. ANIP | 14 | $344 |
| Travere Therapeutics, Inc. TVTX | 13 | $222 |
| Calliditas Therapeutics US Inc. | 7 | $214 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 13 | $206 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 11 | $156 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.